Indicated for: cancer
Route of administration: oral
Substance: procarbazine (antineoplastic agent)
ATC: L01XB01 (Antineoplastic and immunomodulating agents | Other antineoplastic agents | Methylhydrazines)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Procarbazine is an antineoplastic agent used in the treatment of certain types of cancer, such as Hodgkin's lymphoma and other malignant neoplasms. It works by interfering with DNA and RNA synthesis, thereby inhibiting tumor cell growth.
The medication is taken orally, as directed by a doctor, usually as part of a combination chemotherapy regimen. It is important for patients to follow the treatment plan and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as nausea, vomiting, bone marrow suppression, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, and bone marrow suppression. In rare cases, severe reactions such as secondary leukemia or allergic reactions may occur. Patients should be informed of these risks before use.